Tech Company Financing Transactions
Metabolex Funding Round
Metabolex, operating out of Newark, secured $4 million in funding from Birchmere Ventures and Merlin BioMed Group.
Transaction Overview
Company Name
Announced On
1/12/2004
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series C
Investors
Birchmere Ventures (Lead Investor)
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7999 Gateway Blvd. 130
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
Metabolex, Inc. is a privately held pharmaceutical company dedicated to the discovery and development of drugs to treat diabetes and related metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harold Wart
Chief Financial Officer
Sujal Shah
Chief Medical Officer
Pol Boudes
VP - Bus. Development
Patrick O'Mara
VP - R & D
Charles McWherter
Browse more venture capital transactions:
Prev: 1/9/2004: Cellomics venture capital transaction
Next: 1/12/2004: Hydra Biosciences venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs